EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort

Jorge Calderón-Parra, Sara Grillo, Patricia Muñoz, Marina Machado-Vilchez, Antonia Delgado-Montero, Arístides De Alarcón-González, Manuel Poyato-Borrego, M A Goenaga-Sánchez, M Carmen Fariñas-Alvarez, José M Miró, Luis Eduardo López-Cortés, Raquel Rodríguez-García und 3 weitere

Journal of Infection · 2024-12 · 89 (6) · 106352

DOI: 10.1016/j.jinf.2024.106352 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Infection, 2024-12. Verfasst von Jorge Calderón-Parra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Internal Medicine Department, University Hospital Puerta de Hierro, Majadahonda, Madrid, Spain; Research Institute Puerta d…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcal Infections, Propensity Score, Drug Therapy, Combination. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: We aimed to evaluate the usefulness of antistaphylococcal penicillin (ASP) or cephazolin-based combinations versus monotherapy in patients with native-valve infective endocarditis (IE) caused by methicillin-susceptible Staphylococcus aureus (MSSA). METHODS: Post-hoc analysis of a multicentre prospective cohort. We include patients from 2008 to 2022 with definite native-valve, left-side IE due to MSSA treated primarily with ASP/cephazolin. Patients were categorized according to whether they initially received monotherapy or combination therapy for more than 72 h. A propensity score-matched cohort was planned. RESULTS: Out of 420 included cases, 94 (22.4%) received monotherapy and 326 (77.6%) combination. Median combination duration was 14 days (interquartile range 10-20). Sixty-eight combination cases were matched with 68 monotherapy controls. Baseline characteristics were well balanced. There were no differences in in-hospital or one-year mortality between groups (OR 0.85, 95%CI 0.33-2.18 and HR 0.68, 95%CI 0.35-1.31, respectively). Endocarditis relapses and persistent bacteraemia rates were similar (0% vs 1.5%, p = 1.000; and 19.1% vs 13.2%, p = 0.352, respectively). Drug-related adverse events were more frequent in the combination group (15.0% vs 1.1%, p < 0.001). CONCLUSIONS: Antibiotic combinations for patients with native valve left-sided MSSA endocarditis did not improve patient's outcomes. Drug-related adverse events were more frequent in combination patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStaphylococcal InfectionsPropensity ScoreDrug Therapy, CombinationPenicillinsStaphylococcus aureusEndocarditis, BacterialHumansMaleFemaleMiddle AgedProspective StudiesAgedTreatment OutcomeCefazolin

Stichwörter der Autor:innen

Combination therapyInfective endocarditisMortalityPrognosisStaphylococcus aureus

Substanzen

Anti-Bacterial AgentsPenicillinsCefazolin

Autor:innen und Institutionen

  • Infectious Diseases Unit, Internal Medicine Department, University Hospital Puerta de Hierro, Majadahonda, Madrid, Spain; Research Institute Puerta de Hierro-Segovia de Arana (IDIPHSA), Majadahonda, Spain. Electronic ad…
  • Infectious DiseasesUnit, Hospital Santa Creu and Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Infectious Diseases Department, University Hospital Gregorio Marañon, Madrid, Spain; Health research institute Gregorio Marañon, CIBER respiratory diseases-CIBERES (CB06/06/0058), Faculty of Medicine, Complutense Univer…
  • Cardiology Department, University Hospital Gregorio Marañon, Madrid, Spain; CIBER cardiovascular diseases-CIBERCV, Spain.
  • Clinical Infectious Diseases, Microbiology and Parasitology Unit, University Hospital Virgen del Rocio, Sevilla, Spain; CIBER infectious diseases-CIBERINFEC, HealthInstitute Carlos III, Madrid, Spain; Biomedicine Instit…
  • Infectious Diseases Department, University Hospital of Donosti, ISS Bodonostia, San Sebastian, Spain.

Zitieren

APA

Calderón-Parra, J., Grillo, S., Muñoz, P., Machado-Vilchez, M., Delgado-Montero, A., De Alarcón-González, A., Poyato-Borrego, M., Goenaga-Sánchez, M. A., Fariñas-Alvarez, M. C., Miró, J. M., López-Cortés, L. E., Rodríguez-García, R., Oteo, J. A., Martínez-Ramos, A., & Spanish Collaboration on Endocarditis (GAMES) (2024). Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort. Journal of Infection, 89(6), 106352. https://doi.org/10.1016/j.jinf.2024.106352

Vancouver

Calderón-Parra J, Grillo S, Muñoz P, Machado-Vilchez M, Delgado-Montero A, De Alarcón-González A, et al. Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort. Journal of Infection. 2024;89(6):106352. doi:10.1016/j.jinf.2024.106352

BibTeX
@article{CaldernParra2024,
  author = {Calderón-Parra, Jorge and Grillo, Sara and Muñoz, Patricia and Machado-Vilchez, Marina and Delgado-Montero, Antonia and De Alarcón-González, Arístides and Poyato-Borrego, Manuel and Goenaga-Sánchez, M A and Fariñas-Alvarez, M Carmen and Miró, José M and López-Cortés, Luis Eduardo and Rodríguez-García, Raquel and Oteo, José A and Martínez-Ramos, Antonio and Spanish Collaboration on Endocarditis (GAMES), Spanish Collaboration on Endocarditis (GAMES)},
  title = {Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort},
  journal = {Journal of Infection},
  year = {2024},
  volume = {89},
  number = {6},
  pages = {106352},
  doi = {10.1016/j.jinf.2024.106352}
}
Kostenlos starten →